Market Forces Driving Healthtech M&A in 2026

Buyers want to see that your business works on its own. Growth matters, but only when it's backed by unit economics you can explain in five minutes. If you can't, they'll assume the economics don't exist.

PE and strategic buyers are looking at the same metric stack: year-over-year growth, gross margin, burn and runway, net revenue retention, revenue per employee, and sales efficiency. The specifics vary by deal size, but the expectation doesn't. As one investment banker put it, the first 20% EBITDA margin is where most of the value is. After that, buyers shift to growth rate and sustainability.

“We're looking for durability over story.” — Multiple acquirers

This force is the foundation beneath everything else. If your economics aren't legible, the remaining four forces become academic.

Financial and operational hygiene is a closing weapon. The best companies don't “get ready” during diligence. They operate like diligence is always possible: clean books, clean contracts, clear IP posture, security maturity, and cross-functional orderliness.

Don't brush this off as CFO hygiene. It's an operating system.

A Quality of Earnings process that should take three weeks can stretch past two months when financials are messy. Diligence-ready companies move faster, preserve leverage, and close at better terms. Buyers look at HR, contracts, IP, and IT security the same way. They expect holes, but they need to feel like you're in control.

“Quality of Earnings that should take three weeks can stretch to two-plus months when financials are messy.” — Investment banker

Mess creates delays. Delays create doubt. Doubt gets priced, or kills the deal.

There's a structural dead zone in venture-backed healthcare. Revenue-mature companies that aren't big enough for bankers to prioritize and aren't fund-returners worth deep VC time. These aren't broken businesses. They're stuck in an incentives gap.

VCs told us they don't know what to do with the middle 70% of their portfolios. Bankers told us founders show up with six months of runway asking for help, but real processes take six to nine. Acquirers said they'd buy more if companies showed up earlier and cleaner.

“We don't know what to do with the middle 70%. We'd rather recycle capital, but it's awkward to say out loud.” — Partner at mid-tier VC

No one is economically incentivized to tell you the rational move for your company right now. The companies that close are the ones that recognize the gap and act before runway forces their hand.

Runway is a negotiating position, not just a finance metric. Founders wake up to exit planning at roughly six months of runway, but real M&A processes take six to nine months. Sometimes longer. That mismatch destroys leverage and turns a “strategic exit” into a forced outcome.

The hard thresholds we heard repeatedly: less than four months of runway is an automatic no from most buyers. Four to six months means a painful process with low leverage and buyer control. Investment bankers told us the best founder-banker relationships are built two to three years before the transaction.

One pattern worth noting: a corporate inbound that says “don't talk to advisors or bankers” often signals the buyer wants to avoid a competitive process. That's not flattery. It's leverage extraction.

“Engage us 12 to 36 months before you want to transact. If you call us at six months runway, you're asking us to perform a miracle.” — Investment banker

M&A readiness is a 24-month capability. You don't “decide to sell” successfully in 2026. You build a company that can run, raise, or sell in parallel, early enough that the buyer experiences the deal as low-risk optimization, not rescue.

Corporate acquirers don't buy when they're still deciding how to use. They partner to test, then acquire only when the capability is proven, integration risk is understood, and the build-versus-buy decision has resolved in favor of buy.

Partnership is the default. Acquisition is the exception. Corporate M&A is typically for operationally difficult, non-core capabilities that accelerate their roadmap. If the capability looks buildable internally, they usually build. If it's operationally painful, specialized, or time-sensitive, they partner first and buy once proven.

Multiple buyers told us directly that IP moat doesn't win deals anymore. What moves the needle is revenue, logos, team quality, and low integration cost.

“Integration cost matters more than IP quality. If it's too hard to integrate, we'll just build it ourselves or partner deeper.” — Corporate acquirer

Yes, corporates also acquire distressed assets. But those aren't the paydays founders are imagining when they say “we'll sell to a strategic.” Distressed acquisitions happen on the buyer's terms, at the buyer's price, often as talent or technology absorption rather than a premium exit. The rent-to-own path is where the real outcomes live, and it starts years before the transaction.

If your acquisition thesis depends on cold strategic interest without a partnership history, your plan doesn't match how corporates operate.